Funding for this research was provided by:
MOH | National Medical Research Council (NMRC/CG/012/2013)
Received: 19 May 2019
Accepted: 25 February 2020
First Online: 25 March 2020
: S.K. and C.S.V. are the founder directors of Sinopsee therapeutics, a biotech company developing molecules for therapeutic purposes; this work has no conflict with the company. The remaining authors declare no competing interests.